Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
56 studies found for:    "Encephalitis, Japanese"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Completed A Prospective, Open Label Study of Human T Cell Responses to Live Attenuated Japanese Encephalitis Vaccine SA14-14-2
Conditions: Japanese Encephalitis;   Japanese Encephalitis Vaccine
Intervention: Biological: Live attenuated Japanese encephalitis vaccine SA14-14-2
2 Completed
Has Results
Study of a Live Attenuated Japanese Encephalitis Chimeric Virus Vaccine (IMOJEV™) Compared to CD.JEVAX™ in Toddlers
Conditions: Japanese Encephalitis;   Japanese Encephalitis Virus Disease
Interventions: Biological: Live attenuated Japanese encephalitis chimeric virus vaccine;   Biological: Japanese encephalitis live attenuated vaccine (SA14 14 2 vaccine)
3 Completed Determining Safety and Efficacy of Japanese Encephalitis Vaccine When Given With Measles Vaccine
Condition: Encephalitis, Japanese B
Intervention: Biological: Japanese Encephalitis Live Attenuated SA 14-14-2 Vaccine
4 Completed
Has Results
Determining Long-Term Safety and Efficacy of Japanese Encephalitis Vaccine When Given With Measles Vaccine
Condition: Encephalitis, Japanese B
Intervention: Biological: Live attenuated SA 14-14-2 vaccine
5 Completed
Has Results
Immunogenicity and Safety of Inactivated Vero Cell Derived Japanese Encephalitis Vaccine in Thai Children
Condition: Encephalitis, Japanese B
Intervention: Biological: JEVAC
6 Completed
Has Results
Study of Japanese Encephalitis Chimeric Virus Vaccine Given With Measles-Mumps-Rubella Vaccine in Taiwanese Toddlers
Conditions: Japanese Encephalitis;   Measles;   Mumps;   Rubella
Intervention: Biological: Japanese encephalitis chimeric virus: Measles, mumps, and rubella live attenuated virus
7 Active, not recruiting Study of Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in Children Previously Immunized With JE-CV
Conditions: Japanese Encephalitis;   Varicella
Interventions: Biological: Japanese encephalitis chimeric virus;   Biological: Varicella vaccine
8 Completed
Has Results
A Study of Japanese Encephalitis Chimeric Virus Vaccine Compared With SA14-14-2 Vaccine in Infants and Toddlers
Conditions: Encephalitis;   Japanese Encephalitis
Interventions: Biological: Japanese encephalitis chimeric virus vaccine (JE-CV);   Biological: Japanese encephalitis live vaccine (SA14-14-2 vaccine) (CD.JEVAX®)
9 Enrolling by invitation Long-term Follow-up of Immunogenicity of a Single Dose of Japanese Encephalitis Chimeric Virus Vaccine in Toddlers
Conditions: Encephalitis;   Japanese Encephalitis
Intervention:
10 Enrolling by invitation Seroepidemiology of Japanese Encephalitis Virus Infection in Hualien, Taiwan
Condition: Japanese Encephalitis
Intervention:
11 Completed
Has Results
Immunogenicity and Safety of ChimeriVax™ Japanese Encephalitis Vaccine in Thai Toddlers and Children
Conditions: Japanese Encephalitis;   Hepatitis A
Interventions: Biological: Japanese encephalitis vaccine (Day 0) Hepatitis A vaccine (Day 28);   Biological: Hepatitis A vaccine (Day 0) Japanese encephalitis vaccine (Day 28)
12 Completed
Has Results
Study of ChimeriVax™-Japanese Encephalitis Vaccine in Toddlers in Thailand and the Philippines
Conditions: Japanese Encephalitis;   Hepatitis A
Interventions: Biological: Japanese encephalitis vaccine;   Biological: Japanese encephalitis vaccine (Acambis);   Biological: Hepatitis A vaccine
13 Completed Ixiaro as Booster After Mouse-brain Derived Vaccines for Japanese Encephalitis
Condition: Japanese Encephalitis
Interventions: Biological: Mouse brain derived japanese encephalitis vaccine (MB-JEV);   Biological: Primary and booster immunizations with MB-JEV;   Biological: C) primary immunizations with Ixiaro;   Biological: S) Ixiaro booster to MBJEV primed
14 Completed Safety and Efficacy Study of Intravenous Immunoglobulin to Treat Japanese Encephalitis
Condition: Japanese Encephalitis
Intervention: Drug: Intravenous immunoglobulin [ImmunoRel™ (batch 20081217)]
15 Unknown  Treatment of Japanese Encephalitis
Condition: Japanese Encephalitis
Intervention: Drug: Ribavirin
16 Completed
Has Results
Longterm Immunogenicity of the Japanese Encephalitis Vaccine IC51
Condition: Japanese Encephalitis
Intervention: Biological: Japanese Encephalitis purified inactivated vaccine
17 Completed
Has Results
Safety and Tolerability of the Japanese Encephalitis Vaccine IC51
Condition: Japanese Encephalitis
Interventions: Biological: Japanese Encephalitis purified inactivated vaccine (IC51);   Biological: Placebo
18 Completed
Has Results
Rapid Immunization Study of the Japanese Encephalitis Vaccine IC51
Condition: Japanese Encephalitis
Intervention: Biological: IC51
19 Completed Live Attenuated Japanese Encephalitis (JE) Vaccine Coadministered With Measles Vaccine in Infants 9 Months of Age
Condition: Japanese Encephalitis
Intervention: Biological: Japanese encephalitis live attenuated SA 14-14-2 vaccine
20 Completed
Has Results
Immunogenicity Study of the Japanese Encephalitis Vaccine IC51
Condition: Japanese Encephalitis
Interventions: Biological: IC51;   Biological: JE-VAX

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years